Chargement en cours...
Tumor-specific Immunotherapy Targeting the EGFRvIII Mutation in Patients with Malignant Glioma
Conventional therapies for malignant gliomas (MGs) fail to target tumor cells exclusively, such that their efficacy is ultimately limited by non-specific toxicity. Immunologic targeting of tumor-specific gene mutations, however, may allow more precise eradication of neoplastic cells. The epidermal g...
Enregistré dans:
| Auteurs principaux: | , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2008
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2633865/ https://ncbi.nlm.nih.gov/pubmed/18539480 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.smim.2008.04.001 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|